Paul F. Truex - 31 May 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Jun 2022, 21:32:38 UTC
Prior SEC filing
29 Jul 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Minio, Attorney-in-Fact

Key filing fact

Paul F. Truex filed Form 4 for Milestone Pharmaceuticals Inc. (MIST) on 01 Jun 2022.

Key facts

  • This page summarizes Paul F. Truex's Form 4 filing for Milestone Pharmaceuticals Inc. (MIST).
  • 9 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 01 Jun 2022, 21:32.

Change

  • Previous filing in this sequence was filed on 29 Jul 2021.
  • Current net transaction value: +$143,795.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MIST transaction

Common Shares

Options Exercise

Transaction value
$8,978
Shares
+8,016
Change %
Price
$1.12
Shares after
8,016
Date
31 May 2022
Ownership
Direct
MIST transaction

Common Shares

Options Exercise

Transaction value
$69,411
Shares
+45,072
Change %
+562%
Price
$1.54
Shares after
53,088
Date
31 May 2022
Ownership
Direct
MIST transaction

Common Shares

Options Exercise

Transaction value
$35,220
Shares
+22,870
Change %
+43%
Price
$1.54
Shares after
75,958
Date
31 May 2022
Ownership
Direct
MIST transaction

Common Shares

Options Exercise

Transaction value
$2,187
Shares
+822
Change %
+1.1%
Price
$2.66
Shares after
76,780
Date
31 May 2022
Ownership
Direct
MIST transaction

Common Shares

Purchase

Transaction value
$28,000
Shares
+5,000
Change %
+6.5%
Price
$5.60
Shares after
81,780
Date
31 May 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIST transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-8,016
Change %
-100%
Price
$0.000000*
Shares after
0
Date
31 May 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
8,016
Exercise price
$1.12
Footnotes
F1
MIST transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-45,072
Change %
-100%
Price
$0.000000*
Shares after
0
Date
31 May 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
45,072
Exercise price
$1.54
Footnotes
F1
MIST transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-22,870
Change %
-90%
Price
$0.000000
Shares after
2,659
Date
31 May 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
22,870
Exercise price
$1.54
Footnotes
F2
MIST transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-822
Change %
-88%
Price
$0.000000
Shares after
117
Date
31 May 2022
Ownership
Direct
Underlying class
Common Shares
Underlying amount
822
Exercise price
$2.66
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Fully vested and exercisable.

Footnote F2

Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Footnote F3

Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .